Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OptiNose
Biotech
Lyra bags $29.5M to push chronic sinusitis drug into phase 2
Lyra Therapeutics' series B will move its lead program, a rhinosinusitis treatment based on its transmucosal drug delivery platform, into phase 2.
Amirah Al Idrus
Sep 26, 2018 8:17am
Chutes & Ladders—Grail loses a trio of top executives
Nov 3, 2017 9:15am
Fresh from FDA approval, Optinose files for $100M IPO
Sep 20, 2017 4:53am
